Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

January 8, 2026 Drug delivery / Pharma applications

HPBCD in liquid formulations: a systematic study of physical properties and surfactant compatibility

The researchers of TEVA (USA) explored the role of 2-hydroxypropyl-β-cyclodextrin (HPβCD) as an excipient in liquid formulations by evaluating its

Continue reading

January 6, 2026 CD as API / CD derivatives / Pharma applications

Sulfonated, sulfated thioglycosides and multivalence in heparanase inhibition

Heparan sulfate (HS) analogs are synthetic oligo- and polysaccharides designed to mimic or enhance several biological properties of native HS.

Continue reading

January 5, 2026 CD as API / Pharma applications

2,6‑di‑O‑methyl‑3‑acetyl‑β‑cyclodextrin: a novel approach to reducde infectivity of SARS‑CoV‑2 and Japanese encephalitis virus

Among 19 CD derivatives studied, pretreatment of viral particles with DMA-β-CyD significantly reduced infectivity (by 2.25–2.67 log₁₀ units after 180

Continue reading

December 26, 2025 CD as API / Drug delivery / Pharma applications

Neuroprotective effects of statins and cyclodextrins: review and potential role in dementia treatment

Dementia is a progressive and irreversible deterioration in cognition that has a significant impact on the person’s activities of daily

Continue reading

December 23, 2025 CD as API / CD derivatives / Pharma applications

Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis

Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the

Continue reading

December 22, 2025 Drug delivery / Pharma applications

HPBCD and polysorbate containing formulation to eliminate aggregation of a potent osteogenic protein, recombinant human NELL-1

This study utilized a four-stage rational formulation development approach to mitigate aggregation and stabilize a high molecular weight protein, rhNELL-1.

Continue reading

December 19, 2025 CD derivatives / Pharma applications

Cyclodextrin-based carriers for targeted drug delivery, a new review

This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,

Continue reading

a rat is standing on top of a plastic container
December 18, 2025 CD as API / CD derivatives / Pharma applications

Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate

The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to

Continue reading

December 16, 2025 Drug delivery / Pharma applications

A host-guest mediated immunomodulatory hydrogel with sustained antibacterial activity for healing of infected diabetic wounds

To solve the hinderance of infected diabetic wound regeneration and healing, an antibacterial and immunomodulatory hydrogel based on host-guest mediated

Continue reading

December 15, 2025 CD as API / CD derivatives / Pharma applications

Dual activity of low-molecular-weight polymeric β-cyclodextrins against tuberculosis

/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,

Continue reading

Posts pagination

«Previous Posts 1 … 7 8 9 10 11 … 129 Next Posts»

Recent Posts

  • Handbook of Cyclodextrin-Based Enabling Technologies for Overcoming the Solubility and Bioavailability Limitations of Class II, III and IV Drugs
  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins in Phytomedicine

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (71)
  • CD as API (348)
  • CD derivatives (417)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (798)
  • E-ducation (63)
  • Environmental (138)
  • Events (234)
  • Food (225)
  • Gene delivery (22)
  • Household products (1)
  • Household products (5)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (109)
  • Pharma applications (1,191)
  • Supramolecular systems (42)
  • Uncategorized (154)

Top Posts

  • Handbook of Cyclodextrin-Based Enabling Technologies for Overcoming the Solubility and Bioavailability Limitations of Class II, III and IV Drugs
  • Meow! In Japan cyclodextrins are taking cat products to the next level! 😺
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Lanosterol eye drops for cataract treatment
  • Special issue: Recent Trends in Carbohydrate-Based Therapeutics
  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • International Conference on Nanomedicine and Drug Delivery Systems
  • Eva Pharma, DRL, Biocon and Zydus Cadila added to Voluntary Licensing Agreements for Remdesivir

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...